Y. Takao

发表

Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.

K. Itoh, T. Mine, A. Yamada, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA‐A2+ HCV‐Infected Patients

T. Ide, M. Sata, K. Itoh, 2006, Microbiology and immunology.

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.

T. Ide, M. Sata, K. Itoh, 2007, Vaccine.

Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b+ HLA‐A24+ patients

T. Ide, M. Sata, K. Shimotohno, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum levels of IgG to the peptide of HCV1b core at positions 35–44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132–2140 correlated with better prognosis in HCV-infected patients

Y. Nagao, T. Ide, M. Sata, 2007, Medical Microbiology and Immunology.

Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.

T. Ide, M. Sata, K. Itoh, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Nonmutated Self-Antigen-Derived Cancer Vaccine Peptides Elicit an IgE-Independent but Mast Cell-Dependent Immediate-Type Skin Reaction without Systemic Anaphylaxis1

Tomoko Matsumoto, K. Itoh, A. Yamada, 2006, The Journal of Immunology.

Skin Reaction without Systemic Anaphylaxis but Mast Cell-Dependent Immediate-Type Vaccine Peptides Elicit an IgE-Independent Nonmutated Self-Antigen-Derived Cancer

Tomoko Matsumoto, K. Itoh, A. Yamada, 2005 .

Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV

T. Ide, R. Kumashiro, M. Sata, 2008, Digestive Diseases and Sciences.

New epitope peptides derived from parathyroid hormone‐related protein which have the capacity to induce prostate cancer‐reactive cytotoxic T lymphocytes in HLA‐A2+ prostate cancer patients

S. Kamidono, K. Itoh, S. Matsueda, 2005, The Prostate.

Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.

T. Ide, R. Kumashiro, M. Sata, 2006, Hepatology Research.

Antibody Reactive to a Hepatitis C Virus (HCV)‐Derived Peptide Capable of Inducing HLA‐A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV‐Infected Individuals without HLA‐A2 Restriction

M. Sata, K. Itoh, A. Yamada, 2004, Microbiology and immunology.

Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.

M. Sata, K. Itoh, N. Komatsu, 2006, Cellular immunology.

New type of natural antibodies reactive to cytotoxic T lymphocyte-directed cancer vaccine peptides.

K. Itoh, A. Yamada, Y. Miyazaki, 2004, Immunobiology.

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33

T. Ide, M. Sata, K. Itoh, 2007, Cancer Immunology, Immunotherapy.